drugset / Trial / NCT01160276

Drug Interaction Between Colchicine and Calcineurin Inhibitors in Renal Graft Recipients

NCT01160276

Non-randomizedParallel-groupOpen-labelTreatment

Summary

Ciclosporin inhibits P-glycoprotein should increase colchicine bioavailability whereas tacrolimus should not influence colchicine disposition. This is a prospective, controlled, open labeled study performed in renal graft recipients comparing colchicine single dose (1mg) pharmacokinetics in 14 patients treated with tacrolimus and 14 patients treated with cyclosporin.

Timeline

Start
2010-05
Primary completion
2012-01
Completion
2012-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Colchicine Small molecule 1 mg
Comparator Cyclosporine Peptide
Comparator Tacrolimus Small molecule

Indications

No indication recorded.